Fosun Pharma

Aug 11, 2025

Fosun Pharma's Small Molecule Innovative Drug XH-S004 Achieves Overseas Licensing for a Potential Total of $645 Million

Feb 26, 2025

Fosun Pharma Received NMPA Approval for Wan Ti Le (Tenapanor Hydrochloride Tablets)

Feb 17, 2025

Fosun Pharmaceutical Deeply Embraces AI, Self-developed PharmAID Decision Intelligence Platform Boosts Efficient Innovation

Oct 29, 2024

Fosun Pharma Announces 2024Q3 Financial Results

Aug 28, 2024

Fosun Pharma Announces 2024 Interim Results

Apr 26, 2024

Fosun Pharma's Self-developed Artemisinin Medicines Inject New Impetus to Malaria Prevention and Treatment in Africa

Jan 25, 2021

BioNTech and Fosun Pharma Receive Authorization for Emergency Use in Hong Kong for COVID-19 Vaccine

Aug 26, 2020

Fosun Pharma Announces 2020 Interim Results

Jul 14, 2020

Fosun Pharma Announces its Licensed COVID-19 Vaccine Product Receives Acceptance Notice of Clinical Trial Application by NMPA

Apr 29, 2020

Fosun Pharma Invites Chinese and Foreign Experts to Jointly Discuss Prevention and Control Measures of COVID-19 Epidemic in Africa

Apr 19, 2020

Fosun Pharma Receives FDA Emergency Use Authorization (EUA) For Its COVID-19 RT-PCR Detection Kit

Mar 31, 2020

Fosun Pharma Announces 2019 Annual Results

Mar 26, 2020

Fosun Pharma's Novel Coronavirus Nucleic Acid Detection Kit Receives Emergency Approval from China NMPA